11.05.2020 va-Q-tec AG  DE0006636681

DGAP-News: va-Q-tec continues on its growth track in Q1 2020


 

DGAP-News: va-Q-tec AG / Key word(s): Quarterly / Interim Statement
va-Q-tec continues on its growth track in Q1 2020

11.05.2020 / 08:30
The issuer is solely responsible for the content of this announcement.


va-Q-tec continues on its growth track in Q1 2020

  • Revenue growth of 15% in Q1 2020 to EUR 17.6 million, despite slight CoVid-19 effects
  • Services division ("Serviced Rental" of boxes and containers) makes a further strong contribution to revenue trend with growth of +25%
  • EBITDA Q1 2020: EUR 2.8 million (+27%); EBITDA margin improves to 14%
  • Healthcare sector's Q1 2020 revenue share grew significantly to 73% (Q1 2019: 59%)
  • Strong demand for thermal transport solutions for shipping CoVid-19 test kits and therapeutics
  • Despite CoVid-19 effects in Q1 2020, company retains full-year forecast and continues to assume moderate to medium growth


Würzburg, 11 May, 2020. va-Q-tec AG (ISIN DE0006636681 / WKN 663668), a pioneer in highly efficient products and solutions in the thermal insulation (super insulation) and temperature controlled (TempChain) logistics area, today publishes its results for Q1 2020. The company remains on its growth track. In particular, dynamic growth continued in the Services division. As a consequence, the Group's overall profitability also improved further in the first quarter of 2020.

Revenues in Q1 2020 reported a marked overall increase of 15% to EUR 17.6 million (previous year: EUR 15.2 million), with the healthcare sector accounting for 73% of this total (previous year: 59%). The respective divisions' performance varied depending on the CoVid-19-related effects that were clearly noticeable at the end of the quarter.

In the Systems division (sales of thermal packaging), revenue almost doubled to EUR 4.8 million, representing growth of 91% compared with the prior-year period (previous year: EUR 2.5 million). Of particular significance for va-Q-tec in Q1 2020 was a further major order from a leading Scandinavian pharmaceutical distributor and logistics company for several thousand thermal boxes based on va-Q-med(R) technology.

Growth in the Services division was also very gratifying. By renting out containers and boxes for the transport of temperature-sensitive goods, mainly to customers in the life science area (pharmaceuticals, biotech, blood plasma), va-Q-tec increased its revenues by 25% to EUR 8.2 million (previous year: EUR 6.5 million). va-Q-tec benefited here from a significant expansion of its customer base.

The Products division (sales of vacuum insulation panels) recorded a significant decrease in revenues of 28% to EUR 4.2 million (previous year: EUR 5.8 million), particularly as a consequence of the CoVid-19 pandemic and related interruptions at customers' operation sites since March. For the following quarters, va-Q-tec expects catch-up effects in some parts of this business area, but does not expect a return to the previous year's level.

va-Q-tec is also currently playing a contributory role in the fight against coronavirus: with the help of va-Q-tec solutions, several million CoVid-19 test kits have already been shipped worldwide, e.g. from South Korea via Frankfurt to Brazil, and from Singapore to Mongolia and Sri Lanka. More lines will follow these days. Currently more than 50% of all internationally shipped corona test kits are transported in va-Q-tec boxes and containers. In order to treat ill persons as quickly as possible in a targeted manner, fast and reliable diagnostics and tests in large numbers are required. Many test reagents must typically be transported at temperatures below -20 C. The right temperature, time and precision are crucial. va-Q-tec solutions are particularly suitable for secure transport thanks to their unique technology, which keeps the temperature constant between -15 C and -25 C for up to 10 days without energy supply, even under extreme outside conditions. The company is also involved in the worldwide transport of experimental therapeutics against CoVid-19. One of va-Q-tec's largest customers (a US biotech company), whose thermal air freight is handled mainly in va-Q-tainers, reports encouraging results in the approvals process for an Ebola drug in the fight against CoVid-19.

Compared to the same quarter of the previous year, the 27% increase in earnings before interest, tax, depreciation and amortization (EBITDA) outstripped the rate of revenue growth, and reported a rise from EUR 2.2 million to EUR 2.8 million. The EBITDA margin thereby increased from 13% to 14% in terms of total income, and from 15% to 16% in terms of revenues.

Dr. Joachim Kuhn, CEO of va-Q-tec, expresses his satisfaction with the company's start to 2020: "We recognized the great importance of TempChain logistics - in other words, secure transport solutions for temperature-sensitive products such as medicines - years ago, and have since then consistently geared our products and services to the needs of pharmaceutical and biotech customers. Accordingly, we are growing very dynamically in our Systems and Services divisions. The current CoVid-19 pandemic once again impressively demonstrates how crucial globally and locally functioning temperature-controlled logistics chains are for fast and secure supplies. For this reason, we are proud that our temperature-stable and energy-efficient transport solutions enable us to make a significant contribution to the fight against one of the greatest challenges of our time."

Although the actual macroeconomic consequences of CoVid-19 are still uncertain, va-Q-tec sees itself as on track in 2020: despite CoVid-19 effects, the Management Board continues to expect moderate to medium-strong revenue growth while maintaining a constant EBITDA margin. This is thanks, in particular, to the high share of revenues from the healthcare sector, which is expected to be much less affected by CoVid-19 than other sectors of the economy now and in the future.

+++END+++


IR contact

va-Q-tec AG
Felix Rau
Tel.: +49 931 35942 - 2973
Email: [email protected]

cometis AG
Claudius Krause
Tel.: +49 611 - 20 585 5-28
Email: [email protected]


About va-Q-tec
va-Q-tec is a pioneer in highly efficient products and solutions in the area of thermal insulation (super insulation) and temperature controlled (TempChain) logistics. The company develops, produces and markets highly efficient and consequently thin vacuum insulation panels (VIPs) as well as phase change materials (PCMs) for reliable and energy-efficient temperature controlling. In addition, va-Q-tec produces passive thermal packaging systems (containers and boxes) through optimally integrating VIPs and PCMs, which can maintain constant temperatures, depending on type, up to 240 hours without external energy input. To implement temperature-sensitive logistics chains, va-Q-tec - within a global partner network - operates a fleet of rental containers and boxes meeting demanding thermal protection standards. Along with Healthcare & Logistics as the main market, va-Q-tec addresses the following further markets: Appliances & Food, Technics & Industry, Building, and Mobility. The high-growth company, which was founded in 2001, is based in Würzburg, Germany.

Further information: www.va-q-tec.com



11.05.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: va-Q-tec AG
Alfred-Nobel-Straße 33
97080 Würzburg
Germany
Phone: +49 (0)931 35 942 0
Fax: +49 (0)931 35 942 10
E-mail: [email protected]
Internet: www.va-Q-tec.com
ISIN: DE0006636681
WKN: 663668
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1040595

 
End of News DGAP News Service

1040595  11.05.2020 

fncls.ssp?fn=show_t_gif&application_id=1040595&application_name=news&site_id=boersengefluester_html


Die wichtigsten Finanzdaten auf einen Blick
  2017 2018 2019 2020 2021 2022 2023e
Umsatzerlöse1 46,93 50,71 64,67 72,11 104,06 111,83 131,00
EBITDA1,2 7,21 3,03 9,67 11,40 17,79 7,73 10,00
EBITDA-Marge3 15,36 5,98 14,95 15,81 17,10 6,91
EBIT1,4 -0,32 -6,84 -2,56 -0,90 4,14 -7,26 -4,90
EBIT-Marge5 -0,68 -13,49 -3,96 -1,25 3,98 -6,49 -3,74
Jahresüberschuss1 -0,86 -7,73 -2,57 -1,44 1,41 -11,66 -8,00
Netto-Marge6 -1,83 -15,24 -3,97 -2,00 1,36 -10,43 -6,11
Cashflow1,7 1,47 -3,65 7,19 7,41 3,28 9,68 0,00
Ergebnis je Aktie8 -0,07 -0,59 -0,20 -0,11 0,16 -0,87 -0,59
Dividende8 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2022 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: Rödl & Partner

INVESTOR-INFORMATIONEN
©boersengefluester.de
va-Q-tec
WKN Kurs in € Einschätzung Börsenwert in Mio. €
663668 23,400 Halten 345,30
KGV 2025e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
80,69 0,00 0,00 -93,23
KBV KCV KUV EV/EBITDA
8,92 35,67 3,09 51,52
Dividende '22 in € Dividende '23e in € Div.-Rendite '23e
in %
Hauptversammlung
0,00 0,00 0,00 29.08.2023
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
23.05.2023 10.08.2023 09.11.2023 28.04.2023
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
-1,00% -4,91% -4,49% 4,70%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu va-Q-tec AG  ISIN: DE0006636681 können Sie bei EQS abrufen


Oberflächen/Verpackung , 663668 , VQT , HAM:VQT